Clinical trial for Smoking Cessation
Official title Precision Treatment to Promote Smoking Cessation and Survival in Oncology Patients
ClinicalTrials.gov ID: NCT07166120
What this study is testing
- What it's testing
- The study wants to find out if a tailored tobacco treatment, based on a patient’s health and genetic data, can improve quitting rates and treatment use compared to usual care.
- Who it's for
- Cancer patients who smoke and are receiving oncology care.
- What's involved
- Participants will receive a customized smoking‑cessation plan that may include medication and follow‑up visits, while others get the standard care they normally receive.
- Time commitment
- The study lasts about 6 months, with regular clinic visits and follow‑up assessments to track smoking status and treatment use.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 89
You may be able to join if
- Clinician from participating oncology/hematology clinic
- At least 18 years of age
- Patient at participating clinic
- Age 18-89 years
- Current smoking (average cigarettes per day ≥5)
You likely can't join if
- Active use of smoking cessation medication (within the past 30 days)
- Receipt of smoking cessation medication or prescription for smoking cessation medication (within the past 30 days)
- Having a contradiction for cNRT or varenicline (allergic reactions, current cardiac problems, pregnancy)
- Patients who were deemed by the investigator to be ineligible for participation in the trial
See the full eligibility criteria
- Clinician from participating oncology/hematology clinic
- At least 18 years of age
- Patient at participating clinic
- Age 18-89 years
- Current smoking (average cigarettes per day ≥5)
- Can speak and understand English
- Willing to consider medication to help reduce craving or smoking such as nicotine patch, lozenge, or varenicline
- Active use of smoking cessation medication (within the past 30 days)
- Receipt of smoking cessation medication or prescription for smoking cessation medication (within the past 30 days)
- Having a contradiction for cNRT or varenicline (allergic reactions, current cardiac problems, pregnancy)
- Patients who were deemed by the investigator to be ineligible for participation in the trial
The study team makes the final eligibility decision.
Where it is enrolling
- St Louis, Missouri, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 89 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at St Louis, Missouri, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.